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Increased left ventricular (LV) mass in children with chronic renal insufficiency (CRI) might be adaptive to sustain myocardial
performance in the presence of increased loading conditions. It was hypothesized that in children with CRI, LV systolic
function is impaired despite increased LV mass (LVM). Standard echocardiograms were obtained in 130 predialysis children
who were aged 3 to 18 yr (59% boys) and had stages II through IV chronic kidney disease and in 130 healthy children of similar
age, gender distribution, and body build. Systolic function was assessed by measurement of fractional shortening at the
endocardial (eS) and midwall (mS) levels and computation of end-systolic stress (myocardial afterload). The patients with CRI
exhibited a 6% lower eS (33.1  5.5 versus 35.3  6.1%; P < 0.05) and 10% lower mS (17.8  3.1 versus 19.7  2.7%; P < 0.001)
than control subjects in the presence of significantly elevated BP, increased LVM, and more concentric LV geometry. Whereas
the decreased eS was explained entirely by augmented end-systolic stress, mS remained reduced after correction for
myocardial afterload. The prevalence of subclinical systolic dysfunction as defined by impaired mS was more than five-fold
higher in patients with CRI compared with control subjects (24.6 versus 4.5%; P < 0.001). Systolic dysfunction was most
common (48%) in patients with concentric hypertrophy and associated with lower hemoglobin levels. CRI in children is
associated with impaired intrinsic LV contractility, which parallels increased LVM.
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A lterations of cardiac morphology and function are acommon characteristic of ESRD in adult patients andcontribute to the higher cardiovascular risk that is asso-
ciated with this condition (1). Even in the pediatric age, up to 25%
of deaths in patients with ESRD are attributable to cardiovascular
disease (2). Previous echocardiographic studies indicate that
young patients with chronic renal insufficiency (CRI) and ESRD
have abnormal left ventricular (LV) geometry and high prevalence
of LV hypertrophy (LVH) (3–6). We recently reported that sub-
stantial LV remodeling of both concentric and eccentric type oc-
curs also at early stages of CRI in children (7). We found abnormal
LV anatomy mainly related to male gender, anemia, and pon-
derosity but not to BP.
In adults with CRI, LVH is thought to be adaptive initially to
improve pump function and lower wall stress in the face of
increased afterload (BP) and preload (circulating volume) (8).
Consistent with this line of interpretation, normal or even su-
pranormal LV systolic function has been observed in children
with CRI, suggesting that increased LV mass (LVM) may rep-
resent a compensatory response that balances increased hemo-
dynamic load also in young patients (6,9). In a more recent
study in children who were undergoing dialysis, resting LV
systolic performance was increased, possibly attributable to the
presence of LVH, but LV functional reserve during exercise was
decreased, suggesting that LVH actually was maladaptive (10).
In the same study, the response to exercise was normal in
children with mild to moderate CRI, suggesting that different
physiopathologic mechanisms may be operating in LV remod-
eling in predialysis and dialysis patients.
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In adults, assessment of LV systolic function at the chamber
level has been shown to overestimate the real extent of myo-
cardial performance in the presence of concentric LV geometry
(11,12). Analysis of LV shortening at the midwall level (mid-
wall shortening [mS]) more accurately reflects the contractile
force independent of pathologic changes in LV geometry,
which have been demonstrated to preserve LV chamber func-
tion when myocardial contractility is depressed (11). At
present, there is no information on LV wall mechanics in chil-
dren with predialysis CRI. Accordingly, our study was de-
signed to assess whether children with mild to moderate CRI
have impaired LV systolic wall mechanics at rest, independent
of possibly adaptive changes in LV geometry.
Materials and Methods
Patients and Control Subjects
The ongoing Effect of Strict Blood Pressure Control and ACE Inhi-
bition on the Progression of CRI in Pediatric Patients (ESCAPE) trial is
a European multicenter study that is evaluating predialysis white chil-
dren who are being treated for CRI in 33 pediatric nephrology units in
13 European countries (see Acknowledgments); of these, 130 (77 boys
and 53 girls) had echocardiographic recordings that were suitable for
the analysis of both cardiac geometry and systolic function and com-
prised the population of this analysis. Children were studied as part of
the screening procedure for the ESCAPE trial (13). The study protocol,
including echocardiographic examinations, ambulatory BP monitoring,
and biochemical assessments, was designed in adherence to the Dec-
laration of Helsinki and approved by the local ethical committees.
Written informed consent was given from all parents, and informed
consent or assent from the patients was given as appropriate. A group
of 130 normotensive white individuals who were studied in Naples,
Italy, including a school population and normal volunteers (7,14),
formed the normal reference population for our study.
Laboratory Assessments
A full biochemical profile was obtained locally in each center using
standard laboratory techniques, as previously reported (7,13).
Echocardiography
Echocardiograms initially were obtained in 179 children, according
to local procedures and in the absence of standardization of acquisition
methods, using different commercial machines. Videotapes were
shipped to the Reading Center, at the Echocardiography Laboratory of
the Department of Clinical and Experimental Medicine, “Federico II”
University of Naples, for quality check and off-line reading. Quality of
two-dimensional echocardiograms for measurements of LV dimensions
and systolic function was considered sufficient in 130 individuals (73%
of echocardiograms). All echocardiograms were coded and examined
off-line by two independent readers according to standard procedures
(13,15), as previously reported (7). LVM was obtained according to a
necropsy-validated formula (16,17) and normalized for height in meters
to the allometric power of 2.7 (m2.7, LVM index [LVMI]) (18). LVH was
defined as an LVMI 95th percentile of the healthy control subjects (38
g/m2.7) for both male and female individuals, as previously suggested
(7).
For evaluation of the concentricity of LV geometry, myocardial thick-
ness (wallseptum) was divided by LV minor axis (diameter) to gen-
erate a relative wall thickness (RWT), normalized to a mean age of 10
years (19). A value of 0.38 (95th percentile of controls) was used as the
cutoff to define concentric LV geometry (7).
Evaluation of LV Systolic Function
LV systolic function was determined by linear measures of shorten-
ing of LV minor axis both at the endocardial level (endocardial short-
ening [eS]) and at the midwall level (mS) (11,12). Systolic dysfunction
was categorized as mS 16% (the fifth lowest percentile of normal
distribution in the control group of this study).
To account for the effect of myocardial afterload and for the demon-
strated influence of age on the stress/shortening relations, we calcu-
lated circumferential end-systolic wall stress (), a measure of myocar-
dial afterload, assuming a cylindrical geometry (20) and using BP
values that were measured in a sitting position during an office visit.
Because shortening is a negative function of , the derived equation can
be used to predict the corresponding value of both eS and mS for a
given . Thus, age-adjusted, stress-corrected endocardial fractional
shortening (eSc) or stress-corrected mS (mSc) were computed as the
ratio between observed and predicted values and expressed as a per-
centage of the predicted value, using the following equations that were
derived from our reference population (21):
eSc  eS/(90.13 to 24.89  log10 []  0.32 [age]  4.16)  100
mSc  mS/(30.78 to 3.98  log10 []  0.26 [age]  2.75)  100
Therefore eSc and mSc describe LV chamber and myocardial con-
tractility, respectively.
Statistical Analyses
All results are expressed as means  SD. Statistical analysis was
performed using SPSS 12.0 (SPSS, Chicago, IL). Between-group differ-
ences were assessed by ANOVA. The Ryan-Einot-Gabriel-Welsch F post
hoc test for multiple comparisons was used for more than two groups.
2 statistics (with Monte Carlo method to compute exact two-tailed 
value, when appropriate) was used to examine categorical variables.
When appropriate, analysis of covariance was used to control for
potential confounders. Sidak’s adjustment of P value was adopted for
multiple comparisons in analysis of covariance when needed. Two-
tailed P  0.05 was considered statistically significant.
Results
Patient Characteristics
The baseline clinical characteristics of the patients and con-
trol subjects are given in Table 1. Among the 130 patients with
CRI, 33% were class II (i.e., GFR 60 to 89 ml/min per 1.73 m2),
43% class III (GFR 30 to 59 ml/min per 1.73 m2) and 22% class
IV (GFR 15 to 29 ml/min per 1.73 m2). The underlying renal
diseases were renal hypo/dysplasia in 72%, other congenital or
hereditary disease in 16%, and glomerulopathies in 12%.
Whereas age, gender distribution, and anthropometric mea-
sures did not differ between patients and control subjects,
casual office BP was significantly higher in patients with CRI
than in control subjects (P  0.0001).
LV Morphology and Function
As previously reported (7), children with CRI had increased
LV diameter, LVM, and RWT compared with healthy control
subjects (Table 2). eS was slightly lower in children with CRI
than in control subjects (P  0.05). Correction for end-systolic
stress yielded completely normal eS values, suggesting that the
apparent decrease in eS was due entirely to increased myocar-
dial afterload. In contrast, mS was reduced markedly (P 
0.001; Table 2), and this reduction was independent of myocar-
dial afterload as shown by a persistent difference in stress-
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corrected mS (P  0.001). As illustrated in Figure 1, mS was
lower in children with CRI compared with healthy control
subjects at any given value of fractional shortening measured at
the chamber level (P 0.001). The overall prevalence of systolic
dysfunction was increased five-fold in the CRI group (P 
0.01). Systolic dysfunction was significantly more prevalent in
patients with concentric LV geometry (48% of patients) than in
patients with either normal LV geometry or eccentric LVH (P
0.0001; Figure 2).
Characteristics of Children with Systolic Dysfunction
LV mS, expressed either as raw value or corrected for end-
systolic stress, was positively associated with GFR (r 0.20 and
0.21 respectively; each P  0.05) and negatively with RWT (r 
0.42 and 0.52 respectively; each P  0.0001). Children with
normal or impaired systolic function did not differ with respect
to LVMI (36.4  13.5 versus 36.2  12.6 g/m2.7), but those with
systolic dysfunction at the midwall level exhibited greater RWT
(0.36  0.07 versus 0.33  0.05; P  0.005). LV systolic function
was not correlated with any of the BP measures (casual or 24-h
ambulatory BP). Children with reduced systolic function had
lower hemoglobin levels than patients with normal mS (11.8 
1 versus 12.4  1.5 g/dl). Notably, in the patients with subnor-
mal systolic function, mS was inversely correlated with the
current rate of GFR loss (r  0.55, P  0.005).
Discussion
Our study reports on the largest population sample of chil-
dren who have CRI and in whom LV function has been as-
sessed, including intrinsic wall contractility as assessed by com-
putation of echocardiographic parameters that match LV
chamber function and wall mechanics with a reliable measure
of myocardial afterload. This study shows that despite normal
LV chamber function, myocardial dysfunction can be identified
at the midwall level in children and adolescents with mild to
moderate CRI. Similar to adults with arterial hypertension (22),
this pathology is more pronounced in the presence of concen-
tric LV geometry.
In children with CRI, a single report by Colan et al. (23) found
a significantly reduced ejection fraction in children who were
undergoing dialysis, whereas most other previous studies of
children with predialysis or dialysis-dependent CRI showed a
normal or even supranormal ejection fraction at rest (6,9,10,24).
Table 1. Anthropometric and BP characteristics of 130 patients with CRI and 130 healthy control subjectsa
Characteristic Patients with CRI Control Subjects P
Gender (% boys) 59 53 NS
Age (yr) 11.3 4.1 10.6 3.6 NS
Height (cm) 139 20 142  23 NS
Weight (kg) 39.6 16.9 36.9 16.4 NS
BMI (kg/m2) 18.3 3.1 18.0 3.6 NS
Casual systolic BP (mmHg) 118 13 106  9 0.001
Casual diastolic BP (mmHg) 73 11 62 9 0.001
Heart rate (beats/min) 83 19 81 15 NS
Duration of CRI (yr) 6.3 4.4 —
CKD class II/III/IV (%) 33/43/22 —
GFR (ml/min per 1.73 m2) 50 19 —
Urinary protein excretion (mg/m2 per d) 735 1338 —
Blood hemoglobin (g/dl) 12.1 1.6 —
aData are means  SD. BMI, body mass index; CKD, chronic kidney disease; CRI, chronic renal insufficiency.
Table 2. LV morphology and systolic function in 130 patients with CRI and 130 healthy control subjectsa
Parameter Patients with CRI Control Subjects P
LV end-diastolic diameter indexed for height (cm/m) 3.01 0.36 2.91 0.29 0.005
LV mass index (g/m2.7) 36.4 13.2 26.5 6.2 0.001
Relative wall thickness (%) 0.34 0.05 0.30 0.06 0.05
eS (%) 33.1 5.5 35.3  6.1 0.05
mS (%) 17.8 3.1 19.7  2.7 0.001
End-systolic stress (kdynes/cm2) 144 38 126 31 0.002
Age and stress-corrected eS (% predicted) 100.9 12.1 100.4 13.0 NS
Age and stress-corrected mS (% predicted) 91.1 15.6 101.5 13.9 0.001
Reduced systolic function (%) 24.6 4.5 0.01
aeS, endocardial shortening; mS, midwall shortening.
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However, systolic dysfunction is well established in adult pa-
tients who have longstanding CRI and are undergoing dialysis
(25), and mild systolic dysfunction also has been observed in
dialyzed children during exercise testing (4). Therefore, it has
been suggested that the observation of normal (or even su-
pranormal) systolic function in pediatric patients with CRI
represents an adaptive mechanism to increase cardiac output
and improve renal perfusion. However, no previous pediatric
study has analyzed LV function at both the endocardial and the
midwall levels, related LV mechanics to myocardial afterload,
and examined the relationship between systolic function and
LV geometry.
In the two previous studies that assessed LV geometry in
children, concentric LVH was frequent in predialysis CRI, at a
prevalence that might explain the seemingly normal LV func-
tion at the chamber level (6,7). In fact, concentric LV geometry
has been demonstrated to preserve LV chamber function even
when myocardial contractility is depressed (11). We found a
slight reduction of average systolic function at the LV chamber
level; however, this was readily explained by the increased
myocardial afterload (end-systolic stress, as seen in Table 2)
despite increased myocardial wall thickness, suggesting that
the compensatory increase in myocardial thickness was not
sufficient to offset the elevated end-systolic stress. We recently
demonstrated that the hemodynamic pattern of children with
CRI is characterized by a combined pressure and volume over-
load (7). This condition might offset at least in part the effect of
wall thickness (Laplace principle) (26). When endocardial frac-
tional shortening was adjusted for end-systolic stress, LV cham-
ber function in fact was completely normal, providing evidence
that the slight decrease of uncorrected endocardial fractional
shortening was due to an “afterload mismatch” (i.e., the reduc-
tion of net LV chamber performance resulting from increased
afterload that is not fully compensated by an adequate increase
in—albeit normal—endocardial function).
In contrast, mS, a more direct measure of wall mechanics,
was decreased substantially. The reduction remained evident
also after correction for the level of myocardial afterload, high-
lighting a decrease in intrinsic myocardial contractility. Al-
though midwall systolic function was globally correlated with
GFR, we were unable to associate any specific sequelae of CRI
with the impaired myocardial function in this pediatric popu-
lation with mild to moderate chronic kidney disease. The ob-
served slightly lower hemoglobin level in the patients with
systolic dysfunction may indicate a subclinical effect of subop-
timal myocardial oxygenation in early renal anemia.
Our finding of a significant prevalence of subclinical systolic
dysfunction in children with mild to moderate CRI may be of
clinical relevance, because in hypertensive adults with normal
LV chamber function, reduced midwall function is associated
with an unfavorable cardiovascular prognosis (27). Remark-
ably, in patients who exhibited systolic dysfunction, we also
noted a close quantitative relationship between mS and the
current CRI progression rate. It is tempting to speculate about
a putative common mechanism underlying both cardiac dys-
function and progressive loss of renal function, which might
include sympathetic hyperactivation and/or overstimulation of
the renin-angiotensin system at the tissue levels.
Conclusion
LV systolic function measured at the midwall level is de-
creased significantly in children with predialysis CRI. This
impairment is independent of increased myocardial afterload
and BP but linked to concentric LV geometry. In view of similar
observations in adults, the combination of concentric LV geom-
Figure 1. Relationship between fractional shortening (FS%) and
midwall shortening (mS%) in normal control subjects (F, solid
line) and children with chronic renal insufficiency (CRI) and
nonconcentric (, dotted line) or concentric (stars, dashed line)
left ventricular (LV) geometry.
Figure 2. Percentage of patients with impaired systolic function
according to LV geometry (concentric versus eccentric versus
normal geometry) in children with CRI (n  130).
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etry with midwall dysfunction might represent a cardiac phe-
notype designating an increased risk for development of overt
cardiovascular disease.
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